LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY Özgür Pekta¿; Marie Scully; Javier de la Rubia; Katerina Pavenski; Ara Metjian; Paul Knöbl; Flora Peyvandi; Spero Cataland; Paul Coppo; Johanna A. Kremer Hovinga; Jessica Minkue Mi Edou; Rui de Passos Sousa; Sriya Gunawardena; Julie Lin;

EPIDEMIOLOGY, TREATMENT PATTERNS, AND CLINICAL OUTCOMES AMONG PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP) IN THE UNITED STATES: AN ELECTRONIC HEALTH RECORDS ANALYSIS Ayoade Adeyemi; Filip Callewaert; Rui de Passos Sousa; Francesca Razakariasa;